Communicating treatment options to older patients with advanced kidney disease: a conversation analysis study by Selman, LE, Shaw, CB, Sowden, R, Murtagh, FEM, Tulsky, JA, Parry, R, Caskey, FJ, Barnes, RK

Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions by Tong, A, Oberbauer, R, Bellini, MI, Budde, K, Caskey, FJ, Dobbels, F, Pengel, L, Rostaing, L, Schneeberger, S, Naesens, M

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based coh... by Ali, MS, Caskey, FJ, Delmestri, A, Dedman, D, Arden, N, Ben-Shlomo, Y, Abrahamsen, B, Judge, A, Cooper, C, Javaid, MK, Prieto-Alhambra, D

Regional citrate anticoagulation versus systemic heparin anticoagulation for continuous kidney replacement therapy in intensive care by Doidge, JC, Gould, DW, Sadique, Z, Borthwick, M, Hatch, RA, Caskey, FJ, Forni, L, Lawrence, RF, MacEwan, C, Ostermann, M, Mouncey, PR, Harrison, DA, Rowan, KM, Young, JD, Watkinson, P

Heparin versus citrate anticoagulation for continuous renal replacement therapy in intensive care: the RRAM observational study by Gould, DW, Doidge, J, Sadique, MZ, Borthwick, M, Hatch, R, Caskey, FJ, Forni, L, Lawrence, RF, MacEwen, C, Ostermann, M, Mouncey, PR, Harrison, DA, Rowan, KM, Young, JD, Watkinson, PJ

Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis by Robinson, DE, Ali, MS, Pallares, N, Tebé, C, Elhussein, L, Abrahamsen, B, Arden, NK, Ben-Shlomo, Y, Caskey, FJ, Cooper, C, Dedman, D, Delmestri, A, Judge, A, José Pérez-Sáez, M, Pascual, J, Nogues, X, Diez-Perez, A, Strauss, VY, Javaid, MK, Prieto-Alhambra, D